학술논문
Estimating the Prevalence of a True Oligometastatic Disease.
Document Type
Editorial & Opinion
Author
Szturz P; Medical Oncology, Department of Oncology, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland.; Faculty of Biology and Medicine, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.; Bonomo P; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy.; Vermorken JB; Department of Medical Oncology, Antwerp University Hospital, 2650 Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.
Source
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Subject
Language
English
ISSN
2072-6694
Abstract
To delineate a patient group with few distant metastases that could possibly benefit from a curative therapeutic strategy employing a local approach, the term oligometastatic disease (OMD) was introduced into the clinical practice almost 30 years ago [...].